Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer — Stella

Recruiting

Back to Stage II-III Gastric Cancer trials

Trial locations(5 sites)

China

Qilu Hospital of Shandong Univertisy, Jinan, Shandong

Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong

Jinan Central Hospital,, Jinan, Shandong

The Affiliated Hospital of Qingdao University, Qingdao, Shandong

Yantai Yuhuangding Hospital, Yantai, Shandong

Key details

Sponsor

Qilu Hospital of Shandong University

Collaborators

Shandong Provincial Hospital, Jinan Central Hospital

Enrollment target

~197 participants

Started

January 2024

Primary completion

January 2028

Age range

18 Years – 75 Years

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov